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ABSTRACT: Electrophile-mediated disruption of cell signal-
ingisinvolvedinthepathogenesisofseveraldiseasesincluding
atherosclerosis and cancer. Diﬀusible and membrane bound
lipid electrophiles are known to modify DNA and protein
substrates and modulatecellularpathways including ERstress,
antioxidantresponse,DNAdamage,heatshock,andapoptosis.
Herein we report on a structure-activity relationship for
several electrophilic analogues of 4-hydroxynonenal (HNE)
and 4-oxononenal (ONE) with regard to toxicity and anti-
inﬂammatory activity. The analogues studied were the oxida-
tion products of HNE and ONE, HNEA/ONEA, the in vivo
hydrolysis products of oxidized phosphatidylcholine, COOH-
HNE/COOH-ONE, and their methyl esters, COOMe-HNE/
ONE. The reactivity of each compound toward N-acetylcys-
teine was determined and compared to the toxicity toward a
human colorectal carcinoma cell line (RKO) and a human
monocytic leukemia cell line (THP-1). Further analysis was performed in diﬀerentiated THP-1 macrophages to assess changes in
macrophage activation and pro-inﬂammatory signaling in response to each lipid electrophile. HNE/ONE analogues inhibited
THP-1 macrophage production of the pro-inﬂammatory cytokines, IL-6, IL-1β, and TNFR, after lipopolysaccharide (LPS)/IFNγ
activation. Inhibition of cytokine production was observed at submicromolar concentrations of several analogues with as little as
30 min of exposure. Phagocytosis of ﬂuorescent beads was also inhibited by lipid electrophile treatment. Lipid electrophiles related
to HNE/ONE are both toxic and anti-inﬂammatory, but the anti-inﬂammatory eﬀects in human macrophages are observed at
nontoxic concentrations. Neither toxicity nor anti-inﬂammatory activity are strongly correlated to the reactivity of the model
nucleophile, N-acetylcysteine.
’INTRODUCTION
Oxidized phospholipids (oxPL) are generated in vivo as a
result of the inﬂammatory response, mitochondrial respiration,
xenobiotic metabolism, and other processes that generate oxi-
dants. The fatty acyl group esteriﬁed at the 2 position of gly-
cerophospholipdsismono-orpolyunsaturatedandissensitiveto
oxidation to hydroperoxides and cyclic peroxides. The initial
oxidation products decompose to a variety of compounds, some
of which are reactive electrophiles.
1 These electrophiles either
remainesteriﬁedtothephospholipid orcan bereleasedfrom the
membrane and react with cellular targets. The most well-studied
of these electrophiles is the highly reactive R,β-unsaturated
aldehyde, 4-hydroxynonenal (HNE), which can diﬀuse through-
out the cell and modify DNA and protein molecules. Previous
work from our laboratory, using mass spectrometry based
proteomics and microarray analysis, along with work from other
groups,hasdemonstratedtheabilityofHNEtomodulatecellular
pathways including the ER stress response, the antioxidant
response, the DNA damage response, the heat shock response,
and the induction of apoptosis in human colorectal cancer
(RKO) cells.
2-10 Additionally, it is known that oxPLs with
“HNE-like” carbonyl groups at the sn-2 position can be gener-
ated in the plasma membrane and promote macrophage activa-
tion and inﬂammation.
11
When phospholipids are subjected to oxidative stress, a
complexmixtureofreactivecompoundsisformed,anditisoften
diﬃcult to isolate signiﬁcant amounts of individual compounds
ofinterest.Toevaluatethechemicalreactivityandcellulareﬀects
of several of these oxidation products, we synthesized a series of
electrophiles related to HNE and its oxidation product, ONE
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(Scheme1).
12-14BothHNEandONEcanbefurtheroxidizedto
produce their respective metabolites, HNEA and ONEA, which
have also been detected in vivo.
15-19 The COOH-HNE and
COOH-ONE analogues can be formed in vivo by hydrolysis of
the 5-hydroxy-8-oxo-6-octenoic acid ester of 2-lysophophatidyl-
choline(HOOA-PC)andthe 5-keto-8-oxo-6-octenoic acidester
of lysophosphatidylcholine (KOOA-PC), respectively. These
forms of oxidized phosphatidylcholine have been identiﬁed in
oxidized human low-density lipoprotein and are likely hydro-
lyzed by the enzyme platelet-activating factor-acetylhydrolase
(PAF-AH) to produce the carboxylic acid derivative.
20
Each compound was evaluated for electrophilic reactivity
toward N-acetylcysteine and toxicity toward the human colon
carcinoma cell line, RKO, and the human macrophage cell line,
THP-1. HNE and oxPLs are known to inhibit the synthesis of
pro-inﬂammatorycytokines,includingIL-6,IL-12,andTNFR,in
LPS-activated monocytic cell lines.
21-23 Therefore, we per-
formed further analysis in diﬀerentiated THP-1 macrophages
to assess changes in macrophage activation and pro-inﬂamma-
torysignalinginresponsetovariouslipidelectrophiles.Severalof
the HNE- and ONE-analogues signiﬁcantly inhibit the THP-1
macrophage production of IL-6, IL-1β, and TNFR after chal-
lenge with LPS and interferon gamma (IFNγ). Additionally, it
wasfoundthatHNEandONEcouldinhibitTHP-1macrophage
activation as measured by the extent of phagocytosis, under the
same conditions as those that inhibit cytokine production.
’EXPERIMENTAL PROCEDURES
Synthesis of Lipid Electrophiles.
1H and
13C NMR spectra
were collected on a Bruker 300 MHz NMR. HRMS experiments were
carried out at Notre Dame on a Bruker micrOTOF. All reactions were
carried out under an atmosphere of argon. CH2Cl2 was dried using a
solvent purification system. Commercial anhydrous Et3N, DMF, and
CH3CN were used as received. Purification by column chromatography
was carried out on silica gel, and TLC plates were visualized with
phosphomolybdic acid. Although HNE is commercially available, the
purity was sometimes questionable, and therefore, we chose to synthe-
size it. The synthesis of HNE (1), its ester precursor 7, and sulfinate 8
has been previously described in the literature.
2,24
Synthesis of ONE (2). Dess-Martin periodinane (1.8 g, 4.3 mmol)
was added to a solution of 1 (0.52 g, 3.3 mmol) in CH2Cl2 (16 mL).
After 30 min, the reaction mixture was concentrated and purified by
column chromatography (10% EtOAc/hexanes). The product (0.37 g)
was isolated as a yellow oil in 72% yield. The NMR data was consistent
with the literature.
25 1H NMR (CDCl3) δ 9.74 (d, 1H, J = 7.0 Hz), 6.85
(d, 1H, J = 16.2 Hz), 6.73 (dd, 1H, J = 7.0, 16.3 Hz), 2.65 (t, 2H, J = 7.3
Hz), 1.62 (m, 2H), 1.30-1.27 (m, 4H), 0.86 (t, 3H, J = 6.8 Hz);
13C NMR (CDCl3) δ 2 00.1, 193.4, 144.9, 137.2, 41.1, 31.2, 23.3, 22.3,
13.8.
Synthesis of HNEA (3). Aqueous NaOH (0.25 g, 6.3 mmol, 3 mL)
wasaddedtoasolutionof7(0.50g,2.5mmol)inMeOH(12mL).After
stirring overnight, the reaction mixture was acidified with 10% HCl,
saturated with NaCl, and extracted with EtOAc. The product (0.25 g,
58%) was isolated as a colorless oil after purification by column chro-
matography(50%EtOAc/hexanes).TheNMRdatawasconsistentwith
theliterature.
26 1HNMR(CDCl3)δ7.02(dd,1H,J=4.7,15.6Hz),6.36
(br s, 1H), 6.01 (d, 1H, J = 15.6 Hz), 4.31 (dt, 1H, J = 5.1, 5.9 Hz), 1.55
(m, 2H), 1.34-1.22 (m, 6H), 0.86 (t, 3H, J = 5.9 Hz);
13C NMR
(CDCl3) δ 171.5, 152.7, 119.3, 71.0, 36.4, 31.6, 24.8, 22.5, 13.9.
Synthesis of ONEA (4). A solution of CrO3 (1.0 g, 10 mmol) in H2O
(9 mL) and H2SO4 (1 mL) was added to a solution of 1 (0.43 g, 2.8
mmol) in acetone (14 mL). After 30 min, the reaction mixture was
poured into H2O, saturated with NaCl and extracted with EtOAc.
Purification by column chromatography (50% EtOAc/hexanes) yielded
4 (0.19 g, 40%) as a white powder. The NMR data was consistent with
the literature.
27 1H NMR (CDCl3) δ 10.3 (br s, 1H), 7.11 (d, 1H, Jn =
15.9 Hz), 6.64 (d, 1H, J = 15.8 Hz), 2.62 (t, 2H, J = 7.3 Hz), 1.62 (m,
2H),1.30-1.25(m,4H),0.87(t,3H,J=7.3Hz);
13CNMR(CDCl3)δ
199.8, 170.7, 141.0, 129.7, 41.6, 31.2, 23.3, 22.3, 13.8.
Synthesis of 10-(Tetrahydro-2H-pyran-2-yloxy)decanal. A solution
of 3,4-dihydro-2H-pyran (11 mL, 0.12 mol) in CH2Cl2 (100 mL) was
added dropwise to a milky solution of 1,10-decanediol (21 g, 0.12 mol)
and p-toluenesulfonic acid (4.6 g, 0.20 mol) in CH2Cl2 (300 mL). After
3 h, the reaction mixture was washed with saturated NaHCO3and dried
over MgSO4. Purification by column chromatography (20% EtOAc/
hexanes) yielded the product (13 g, 41%) as a colorless liquid. Pyri-
dinium chlorochromate (16 g, 0.074 mol) was added to a solution of
10-(tetrahydro-2H-pyran-2-yloxy)decan-1-ol (13 g, 0.049 mol) in
CH2Cl2 (200 mL). After 1 h, the reaction mixture was diluted with
ether and filtered through Celite. The product was purified by column
chromatography (10% EtOAc/hexanes) and isolated as a colorless
liquid (10 g, 81%). The NMR data was consistent with the literature.
28
1H NMR (CDCl3) δ 9.73 (t, 1H, J = 1.9 Hz), 4.54 (t, 1H, J = 2.8 Hz),
3.83 (m, 1H), 3.69 (dt, 1H, J = 6.9, 9.5 Hz), 3.46 (m, 1H), 3.34 (dt, 1H,
J = 6.6, 9.5 Hz), 2.38 (dt, 2H, J = 1.9, 7.3 Hz), 1.80-1.68 (m, 4H),
1.56-1.50 (m, 6H), 1.1.35-1.25 (m, 10H);
13C NMR (CDCl3)
δ 202.9, 98.8, 67.6, 62.3, 43.8, 30.7, 29.7, 29.32, 29.28, 29.2, 29.1,
26.1, 25.4, 22.0, 19.6.
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Synthesis of 9. Piperidine (5.0 mL, 0.051 mol) was added to a
solution of sulfinate 8 (7.4 g, 0.033 mol) and 10-(tetrahydro-2H-pyran-
2-yloxy)decanal (10 g, 0.039 mol) in CH3CN. After stirring overnight,
the reaction mixture was diluted with saturated NH4Cl and extracted
with EtOAc. The organic layer was washed with brine and dried over
MgSO4. The product (8.9 g) was isolated in 79% yield after purification
by column chromatography (20 to 30% EtOAc/hexanes).
1H NMR
(CDCl3)δ6.90(dd,1H,J=5.0,15.7Hz),5.98(dd,1H,J=1.6,15.Hz),
4.53 (t, 1H, J=2.7 Hz), 4.24 (m, 1H),4.15 (q,2H, J =7.1 Hz),3.82 (m,
1H),3.68(dt,1H,J=6.8,9.5Hz),3.45(m,1H),3.33(dt,1H,J=6.6,9.5
Hz), 2.12 (br d, 1H, J = 4.6 Hz), 1.79-1.70 (m, 2H), 1.54-1.47 (m,
8H), 1.30-1.26 (m, 10H), 1.25 (t, 3H, J = 7.1 Hz);
13C NMR (CDCl3)
δ 166.5, 150.3, 120.0, 98.8, 71.0, 67.6, 62.3, 60.4, 36.6, 30.7, 29.6, 29.4,
29.3, 26.1, 25.4, 25.1, 19.6, 14.2, 14.1; HRMS(ESI) calculated 365.2304
(M þ Na), observed 365.2285.
Synthesis of 10. TBDMSCl (4.8 g, 0.032 mol) and imidazole (2.7 g,
0.040 mol) were added to a solution of 9 (8.9 g, 0.026 mol) in DMF
(65 mL). After stirring overnight, the reaction mixture was diluted with
H2OandextractedwithEtOAc.Theorganiclayerwaswashedwithbrine
and dried over MgSO4. The product was purified by column chroma-
tography (10%EtOAc/hexanes) andisolatedasacolorlessliquid(9.6g,
81%).
1HNMR(CDCl3)δ6.88(dd,1H,J=4.7,15.5Hz),5.92(dd,1H,
J=1.7,15.5Hz),4.54(t,1H,J=2.7Hz),4.25(m,1H),4.16(dq,2H,J=
1.7, 7.2 Hz), 3.83 (m, 1H), 3.69 (dt, 1H, J = 6.9, 9.5 Hz), 3.46 (m, 1H),
3.34 (dt, 1H, J = 6.6, 9.6 Hz), 1.73 (m, 2H), 1.56-1.47 (m, 8H),
1.30-1.27(m,10H),1.26(t,3H,J=7.1Hz),0.87(s,9H),0.02(s,3H),
0.0 (s, 3H);
13C NMR (CDCl3) δ 166.7, 151.1, 119.6, 98.8, 71.5, 67.6,
62.3, 60.2,37.3,30.7, 29.7,29.5,29.40,29.35,26.2, 25.8,25.6,25.4, 24.7,
19.6, 18.1, 14.2, -4.7, -5.0; HRMS (ESI) calculated 479.3177 (M þ
Na),observed479.3165.Toasolutionofthisproduct(9.6g,0.021mol)
in diethyl ether (100 mL) was added MgBr2-Et2O (17 g, 0.064 mol).
After 6 h, the reaction mixture was diluted with H2O and extracted with
EtOAc.Theorganiclayerwaswashedwithbrine,driedoverMgSO4and
purified by column chromatography (20 to 30% EtOAc/hexanes). The
product (5.2 g) was isolated as a colorless liquid in 66% yield.
1H NMR
(CDCl3) δ 6.88 (dd, 1H, J = 4.7, 15.5 Hz), 5.92 (dd, 1H, J = 1.7, 15.5
Hz),4.25(m,1H),4.15(dq,2H,J=1.6,7.1Hz),3.59(t,2H,J=6.6Hz),
1.54-1.45 (m, 4H), 1.30-1.26 (m, 10H), 1.25 (t, 3H, J = 7.1 Hz), 0.87
(s, 9H), 0.01 (s, 3H), 0.00 (s, 3H);
13C NMR (CDCl3) δ 166.8, 151.1,
119.6, 71.5, 62.9, 60.3, 37.2, 32.7, 29.44, 29.38, 29.3, 25.8, 25.6, 24.7,
18.1, 14.2, -4.7, -5.0; HRMS (ESI) calculated 373.2769 (M þ H),
observed 373.2771.
Synthesis of 11. Bleach (30 mL, 0.024 mol) was added to a rapidly
stirring solution of 10 (5.2 g, 0.014 mol), Tempo (0.20 g, 0.0013 mol),
NaBr (1.1 g, 0.010 mol), Bu4NBr (0.90 g, 0.003 mol), and NaHCO3
(3.0 g, 0.035 mol) in CH2Cl2 (50 mL) and H2O (20 mL). The reaction
mixtureturnedorangeasthebleachwasadded,thenthecolordissipated.
If the reaction was not complete within 30 min, additional bleach was
added. The reaction mixture was acidified with 10% HCl, saturated with
NaCl, and extracted with EtOAc. The organic layer was dried over
MgSO4, filtered, and concentrated. Purification by column chromatog-
raphy (30% EtOAc/hexanes) yielded 11 (4.1 g) in 75% yield.
1H NMR
(CDCl3) δ 6.87 (dd, 1H, J = 4.7, 15.5 Hz), 5.92 (dd, 1H, J =1.7, 15.5
Hz),4.25(m,1H),4.16(dq,2H,J=1.6,7.1Hz),2.30(t,2H,J=7.4Hz),
1.57(m,2H),1.46(m,2H),1.30-1.26(m,8H),1.25(t,3H,J=7.1Hz),
0.86 (s, 9H), 0.01 9s, 3H), -0.01 (s, 3H);
13C NMR (CDCl3) δ 179.6,
166.8, 151.1, 119.6, 71.5, 60.3, 37.2, 33.9, 29.3, 29.0, 28.9, 24.6, 24.5,
18.1, 14.2, -4.7, -5.0; HRMS (ESI) calculated 387.2561 (M þ H),
observed 387.2551.
Synthesis of 12. DIBAL-H (1 M/toluene, 35 mL, 0.035 mol) was
added slowly to a solution of 11 (4.1 g, 0.011 mol) and Et3N (2.3 mL,
0.017 mol) in CH2Cl2 (55 mL) at 0 C. After 30 min, the reaction
mixture was slowly quenched with 10% HCl and saturated with
NaCl. The organics were extracted with EtOAc and dried over MgSO4.
The product was purified by column chromatography (50% EtOAc/
hexanes) and isolated as a pale yellow liquid (1.7 g, 48%).
1H NMR
(CDCl3)δ5.75-5.59 (m, 2H),4.12-4.05 (m,3H),2.30 (t,2H, J=7.4
Hz),1.58(m,2H),1.43(m,2H),1.30-1.25(m,8H),0.85(s,9H),0.01
(s, 3H), -0.01 (s, 3H);
13C NMR (CDCl3) δ 179.1, 134.4, 128.1, 72.7,
63.1, 38.1, 34.0, 29.2, 29.0, 28.7, 25.9, 25.8, 24.8, 24.6, 18.2, 14.2, -4.3,
-4.9; HRMS (ESI) calculated 367.2275 (M þ Na), observed 367.2253.
Synthesis of 13. Dess-Martin periodinane (1.8 g, 4.2 mmol) was
addedtoasolutionof12(1.1g,3.3mmol)inCH2Cl2(16mL).After1.5
h, the reaction mixture was diluted with EtOAc and washed with H2O
and brine, and dried over MgSO4. Purification by column chromatog-
raphy (30% EtOAc/hexanes) yielded 13 as a colorless oil (0.64 g, 57%).
1HNMR(CDCl3)δ9.50(d,1H,J=8.0Hz),6.75 (dd,1H,J=4.5,15.5
Hz), 6.20 (ddd, 1H, J = 1.5, 8.0, 15.5 Hz), 4.35 (m, 1H), 2.28 (t, 2H, J =
7.4 Hz), 1.56-1.50 (m, 4H), 1.30-1.20 (m, 8H), 0.85 (s, 9H), 0.00 (s,
3H), -0.03 (s, 3H);
13C NMR (CDCl3) δ 193.8, 179.9, 160.4, 130.5,
71.5, 37.0, 33.9, 29.2, 29.0, 28.8, 25.7, 24.6, 24.5, 18.1, -4.8, -5.0;
HRMS (ESI) calculated 343.2299 (M þ H), observed 343.2286.
SynthesisofCOOH-HNE(5). AqueousHF(1mL,5%v/v)wasadded
to a solution of 13 (0.64 g, 1.9 mmol) in CH3CN (18 mL). After 1.5 h,
the reaction mixture was adjusted to pH 4 with saturated NaHCO3,
saturated with NaCl, and extracted with EtOAc. The organic layer was
dried over MgSO4 and concentrated. Note: The solution should NOT
beconcentratedtodryness,ordecompositionoftheproductwillresultif
trace amounts of HF are still present. The product was purified by
column chromatography (50% EtOAc/hexanes) and isolated as a white
powder (0.17 g, 40%).
1H NMR (CDCl3) δ 9.54 (d, 1H, J = 7.9 Hz),
6.80(dd,1H,J=4.7,15.7Hz),6.27(ddd,1H,J=1.4,7.9,15.7Hz),4.39
(m, 1H), 2.31 (t, 2H, J = 7.4 Hz), 1.61-1.56 (m, 4H), 1.35-1.25 (m,
8H);
13C NMR (CDCl3) δ 193.8, 179.5, 159.2, 130.6, 71.0, 36.3, 33.9,
29.1, 28.9, 28.8, 25.0, 24.5; HRMS (ESI) calculated 229.1434 (M þ H),
observed 229.1426.
Synthesis of COOH-ONE (6). Dess-Martin periodinane (0.15 g, 0.35
mmol) was added to a solution of 5 (0.067 g, 0.29 mmol) in CH2Cl2
(2mL).After1h,thereactionmixturewasconcentratedandpurifiedby
column chromatography (50% EtOAc/hexanes). The product was
isolated as a white powder (0.052 g, 79%).
1H NMR (CDCl3) δ 9.76
(d, 1H, J = 6.9 Hz), 6.86 (d, 1H, J = 16.2 Hz), 6.75 (dd, 1H, J =6.6, 16.2
Hz), 2.67 (t, 2H, J = 7.2 Hz), 2.33 (t, 2H, J = 7.4 Hz), 1.66-1.59 (m,
4H), 1.35-1.28 (m, 6H);
13C NMR (CDCl3) δ 200.0, 193.4, 178.7,
144.9, 137.4, 41.1, 33.7, 29.0, 28.83, 28.78, 24.6, 23.5; HRMS (ESI)
calculated 249.1097 (M þ Na), observed 249.1085.
Synthesis of 14. This procedure was carried out using the mini
Diazald diazomethane generator from Aldrich (St. Louis, MO). A
solution of Diazald (1.6 g, 7.5 mmol) in ether (35 mL) was added
dropwisetoasolutionofKOH(1.4g,25mmol)inH2O/EtOH(45mL,
1:1) at 65 C. The CH2N2 was condensed into a reaction flask
containing a solution of 12 (1.6 g, 4.7 mmol) in ether (20 mL) at
0 C. After the addition was complete, the reaction mixture was stirred
for 30 min to dissipate any unreacted CH2N2. The solution was con-
centrated, and purification by column chromatography (20% EtOAc/
hexanes) yielded 14 (1.2 g, 69%).
1H NMR (CDCl3) δ 5.76-5.59 (m,
2H),4.12-4.05(m,3H),3.63(s,3H),2.27(t,2H,J=7.4Hz),1.58(m,
2H), 1.43 (m, 2H), 1.30-1.20 (m, 8H), 0.86 (s, 9H), 0.01 (s, 3H),
-0.01 (s, 3H);
13C NMR (CDCl3) δ 174.3, 135.2, 128.2, 72.6, 63.1,
51.4, 38.1, 34.0, 29.3, 29.1, 29.0, 25.8, 25.0, 24.8, 18.2, -4.3, -4.8;
HRMS (ESI) calculated 381.2432 (M þ Na), observed 381.2424.
Synthesis of COOMe-HNE (15). Dess-Martin periodinane (1.4 g, 3.4
mmol) was added to a solution of 14 (1.0 g, 2.8 mmol) in CH2Cl2 (14
mL). After 1 h, the reaction mixture was concentrated and purified by
column chromatography (10 to 20% EtOAc/hexanes) yielding the
product (0.80 g, 81%) as a colorless liquid.
1H NMR (CDCl3) δ 9.53
(d,1H,J=8.0Hz),6.76(dd,1H,J=4.5,15.5Hz),6.21(ddd,1H,J=1.5,
8.0, 15.5 Hz), 4.36 (m, 1H), 3.62 (s, 3H), 2.26 (t, 2H, J = 7.4 Hz),360 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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1.60-1.52 (m, 4H), 1.30-1.20 (m, 8H), 0.87 (s, 9H), 0.02 (s, 3H),
-0.01 (s, 3H);
13C NMR (CDCl3) δ 193.6, 174.2, 160.2, 130.6, 71.5,
51.4, 37.0, 34.0, 29.3, 29.0, 28.9, 25.7, 24.8, 24.7, 18.1, -4.7, -5.0;
HRMS (ESI) calculated 379.2275 (M þ Na), observed 379.2287. To a
solution of this aldehyde (0.80 g, 2.2 mmol) in CH3CN (14 mL) was
addedaqueousHF(0.6mL,5%v/v).After1h,thereactionmixturewas
neutralized with saturated NaHCO3 and extracted with EtOAc. The
organiclayerwaswashedwithbrineanddriedoverMgSO4.Theproduct
was isolated as a pale yellow liquid (0.41 g, 76%) after purification by
column chromatography (30% EtOAc/hexanes).
1H NMR (CDCl3) δ
9.54 (d, 1H, J = 7.9 Hz), 6.79 (dd, 1H, J = 4.7, 15.7 Hz), 6.27 (ddd, 1H,
J=1.5,7.9,15.7Hz),4.40(m,1H),3.63(s,3H),2.27(t,2H,J=7.4Hz),
1.62-1.56 (m, 4H), 1.35-1.25 (m, 8H);
13C NMR (CDCl3) δ 193.6,
174.3, 159.1, 130.6, 71.0, 51.5, 36.4, 34.0, 29.2, 29.0, 28.9, 25.1, 24.8;
HRMS (ESI) calculated 265.1410 (M þ Na), observed 265.1396.
Synthesis of COOMe-ONE (16). Dess-Martin periodinane (0.43 g,
1.0mmol) wasaddedtoasolutionof15(0.20g,0.84mmol)inCH2Cl2
(4mL).After1h,thereactionmixturewasconcentratedandpurifiedby
column chromatography (20% EtOAc/hexanes). The product was
isolated as a yellow liquid (0.13 g, 64%).
1H NMR (CDCl3) δ 9.73
(d, 1H, J = 7.0 Hz), 6.84 (d, 1H, J = 16.2 Hz), 6.72 (dd, 1H, J = 7.0, 16.2
Hz), 3.61 (s, 3H), 2.64 (t, 2H, J = 7.3 Hz), 2.25 (t, 2H, J = 7.4 Hz),
1.62-1.54 (m, 4H), 1.35-1.25 (m, 6H);
13C NMR (CDCl3) δ 200.0,
193.4, 174.2, 144.8, 137.3, 51.4, 41.1, 33.9, 28.9, 28.8, 28.7, 24.7, 23.4;
HRMS (ESI) calculated 263.1254 (M þ Na), observed 263.1266.
Cell Culture. Human colorectal carcinoma (RKO) cells were
obtained from American Type Culture Collection (ATCC) (Manassas,
VA)andmaintainedinHEPESbufferedDMEMþGlutaMaxmediumfrom
Invitrogen (Carlsbad, CA), supplemented with 10% fetal bovine serum
(FBS) from Atlas Biologicals (Fort Collins, CO), 1  MEM vitamins from
Mediatech (Herndon, VA), and 1  antibiotic/antimycotic (Invitrogen),
and harvested/lysed as described previously.
4
Human monocytic leukemia (THP-1) cells were obtained from
ATCC and maintained in RPMI 1640 medium (Invitrogen) supple-
mented with 10% FBS (Atlas Biologicals), 1 mM L-glutamine, 1 
antibiotic/antimycotic (Invitrogen), and 1  MEM vitamins from
(Mediatech). Cells from suspension cultures were plated at approxi-
mately 10
7 cells/plate in 150 mm plates and treated with 100 nM
phorbol myristate acetate (PMA) from Sigma-Aldrich (St. Louis, MO)
for 72-96 h to induce diﬀerentiation. Cells adhered to the plates and
were challenged with various concentrations of lipid electrophile or
vehiclecontrol.Alllipidelectrophileswerepreparedasa1000 stockin
DMSO and diluted into cell culture medium, which unless otherwise
stated, contained FBS for treatment. Thirty minutes postexposure, cells
were washed twice with phosphate buﬀered saline (PBS) and treated
with 50 ng/mL of LPS (Sigma) and 10 U/mL IFNγ for various times.
Cells were harvested by scraping and were pelleted at 1,000 rpm for
5minat4C.CellswerewashedtwiceinicecoldPBSandbroughtupin
0.2 mL/plate of M-PER extraction buﬀer from Thermo Scientiﬁc
(Rockford,IL)þ1%proteaseinhibitorcocktail(Sigma)formammalian
tissueculture.Sampleswereleftonicefor20minandthencentrifugedat
10,000g for 15 min, whereupon the supernatant was collected, and
protein concentration was determined using the BCA assay (Thermo
Scientiﬁc).
Cell Viability Assay. RKO cells were maintained as described pre-
viously and seeded into 96-well plates (7.5   10
3 cells/well). After 24 h,
cells were challenged with various concentrations of lipid electrophile
(0-500 μM) in the presence of serum. For serum free experiments,
RKOcellswereseedednormallyfor24h,butelectrophiletreatmentwas
done with DMEM medium lacking FBS. Following a 24-48 h treat-
ment, the cells were washed with PBS and incubated with 2 μM calcein-
AM from Molecular Probes (Carlsbad, CA) for 30 min. In live cells,
calcein-AM is cleaved by an endogenous esterase to produce the
fluorescentcalcein(λabs=494;λem=517).Fluorescence wasmonitored
using a Spectramax Multiwell plate reader (Molecular Devices, Silicon
Valley, CA), and cell viability was correlated with fluorescent intensity.
THP-1 cells were maintained as described previously, seeded into
96-well plates (3 10
4 cells/well), and treated with 100 nM PMA for
72-96htodiﬀerentiate.Followingdiﬀerentiation,cellswerechallenged
with the lipid electrophile for 24 h before being read using the calcein
AM assay (described above).
Reactivity Index. Half-Life Determination. The half-lives for the
series of HNE and ONE analogues was determined by the reaction of
each compound with N-acetyl cysteine (NAC) at 37 C. The consump-
tionofthe electrophilewas monitoredbyUV (HNEat225 nm,ONEat
230 nm), which was fitted with a circulating bath to maintain the
temperature of the sample holder at 37 C. Stock solutions of the
electrophiles (34mM)andN-acetylcysteine (56 mM)weremade up in
MeOH or sodium phosphate buffer (50 mM, pH 7.4), respectively.
NAC (55μL)wasadded to phosphate buffer(3mL)inaquartzcuvette
and used as the blank. To this solution, which was pre-equilibrated at
37C,wasaddedtheelectrophile (5μL). Thefinalconcentrations were
0.056 mM electrophile and 1 mM NAC, maintaining pseudofirst-order
conditions. UV analysis was started immediately upon the addition of
the electrophile. The absorbance of the HNE analogues was measured
every5minfor2h,longenoughforcompletereaction.Measurementsof
theONEanaloguesweretakenevery3sfor5min,withtheexceptionof
ONEA. Since this compound was considerably slower than the other
ONE analogues, measurements were taken every 5 min for 2 h. This
experimentwascarriedoutinquadruplicatewithfreshstocksolutionsof
NAC. The stability of each compound to the reaction conditions was
measured in the same manner but in the absence of NAC.
The UV measurement at each time point was corrected for back-
ground absorbance based on the absorbance reading upon complete
reaction of the electrophile (at least 5 half-lives). A plot of -ln(At/A0)
versus time gives a linear correlation for early time points (prior to the
consumption of the electrophile). The ﬁrst order rate constant was
determined from the slope, which was then converted to a half-life.
These plots are presented in the Supporting Information.
HPLC Analysis of HNEA Reaction with NAC. The λmax for HNEA
shiftedfrom225to210nmascomparedtotheparentHNEcompound.
Since it was possible that NAC or products could absorb in this region,
the reaction of HNEA with NAC was also monitored by HPLC. The
sample was made up as described above, with the addition of cinnamyl
alcohol (0.1 mM) as an internal standard. The reaction was monitored
by reverse-phase HPLC (C18 column) using 9:1 MeOH/H2O (0.05%
TFA) at a flow rate of 1 mL/min. The amount of HNEA relative to the
internal standard was measured at 210 nm every 10 min for 90 min. A
plot of the amount of HNEA remaining versus time showed no reaction
of the HNEA with NAC, consistent with the UV experiment described
above.
Second-Order Rate Constant. The second-order rate constant was
determined under the conditions described above except that the
reaction was carried out in 100 mM phosphate buffer (pH 7.4). The
higherconcentrationofbufferwasnecessarytomaintainthepHat7.4at
the higher concentrations of NAC. The consumption of the HNE
analogues and ONEA was measured at varying concentrations of NAC
ranging from 0.46 to 4.6 mM. Since the ONE analogues react much
faster with NAC, these experiments were carried out under more dilute
conditions (0.084-0.84 mM NAC) so that the consumption could be
moreaccurately measured. Thefirstorder rate constantwasdetermined
as described above, then plotted versus the [NAC]. The slope of the
latter plotwas used to determinethe second order rate constant(Figure
S3, Supporting Information).
WesternBlot. THP-1cellsweregrown,differentiated,treatedwith
lipid electrophiles and LPS, and harvested as described above. Samples
were quantified by the BCA assay, and 10 μg/well of each sample
was run on a 12% (Tris-HCl) SDS gel from Biorad (Hercules, CA).361 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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Gelsweretransferredontoa0.45μmnitrocellulosemembrane(Biorad),
themembranewasblockedfor1husing5%nonfatdrymilkin1 TTBS
(0.1% Tween 20 þ Tris buffered saline), and then reacted with appro-
priate target antibodies [1:250-1:1000 dilutions in 1  TTBS þ 1%
nonfat dry milk from Abcam (Cambridge, MA)] overnight at 4 C. The
blot was washed 4 time for 15 min in 1  TTBS, incubated with
secondary antibody [1:1,000 dilution from Santa Cruz (Santa Cruz,
CA)] for1 hatroomtemperature, andwashed3times for15minin 1 
TTBS. Blots were visualized using SuperSignal West Pico Chemilumi-
nescent Substrate ECL reagent (Thermo Scientific) and developed on
Chemiluminescent-XPosureClearBlueX-rayFilm(ThermoScientific).
Enyzme-Linked Immunosorbent Assay (ELISA). All re-
agents and buffers for the ELISA plate assay were obtained from BD
Biosciences (San Jose, CA). For acute exposure experiments, THP-1
cellsweretreatedwithDMSO,HNE(0-200μM),ONE(0-200μM),
HNEA (0-200 μM), or ONEA (0-200 μM) for 30 min, washed twice
with PBS, and challenged for various times with LPS (in the absence of
electrophiles). For continuous exposure experiments, the experimental
design was the same as that with acute exposure; however, lipid
electrophiles remained in the media concurrent with LPS activation.
Onemilliliterofconditionedmediawasremovedforsampleanalysis.All
samples were diluted 1:50 or 1:10 in Standard/Sample Diluent Buffer
andprocessedasperBDOptEIAHumanIL-6/IL-1β/TNFRELISAKit
II (#550799, #557966, and #550610) specifications. Samples were
quantified usingacytokine specific standard curve(standards provided)
that was prepared in parallel. Cytokine levels were determined by
measuring absorbance at 450 nm on a Spectramax Multiwell plate
reader.
Phagocytosis/Fluorescence Microscopy. THP-1 cells were
seeded at 1.5   10
6 cells/well onto glass coverslips (VWR, West
Chester, PA) in 6-well tissue culture plates. Cells were differentiated
with 100 nM PMA for 72 h, washed, and treated with 10 μM HNE,
0.5μMONE,orvehiclefor30min.Following30minofincubation,cells
were washed twice with PBS and exposed to opsonized 2.0 μm
fluorescent polystyrene latex beads (Fluoresbrite YG Microspheres
2.00 μm, #18338-5; Polysciences Inc., Warrington, PA) in media for
3 or 6 h. One drop (20 μL) of beads was opsonized by incubation with
10%FBSfor60minat37C.Followingexposuretothebeads,cellswere
washedtwicewithPBSandfixedfor15minina2.5%paraformaldehyde
solution. Beads were visualized using a Zeiss Axioplan fluorescence
microscope with a green fluorescent protein (GFP) filter.
’RESULTS
SynthesisofLipidElectrophiles. ThesynthesisofHNEand
its ester precursor (7) has been previously described.
2 The more
highly oxidized analogues, ONE and ONEA, were synthesized
fromHNEemployingeither aDess-Martin periodinaneorJones
oxidation,respectively(Scheme2).
29-32HNEAwassynthesized
by simple hydrolysis of ester 7. The carboxy analogues were
synthesized utilizing the same strategy as that in HNE synthesis
(Scheme3).Sulfinate8wascoupledtotheappropriatealdehyde
to yield R,β-unsaturated ester 9. Protecting group manipulation
followed by a Tempo-mediated oxidation yielded the carboxy
ester 11. Reduction of the ester with DIBAL-H generated the
alcohol 12. This intermediate was used for the synthesis of the
carboxy-analogues as well as their corresponding methyl esters.
The alcohol was oxidized to the aldehyde using Dess-Martin
periodinane. Deprotection with aqueous HF yielded COOH-
HNE and further oxidation yielded COOH-ONE. Other com-
mon oxidation conditions, such as Swern and PCC, resulted in
lower yields of the desired product. In addition, after screening
Scheme 2. Synthesis of HNE, ONE, HNEA, and ONEA
a
aReagents: (a) Dess-Martin periodinane, CH2Cl2; (b) NaOH, H2O/
MeOH; (c) CrO3,H 2O/H2SO4, acetone.
Scheme 3. Synthesis of COOH-HNE, COOH-ONE, and Corresponding Esters
a
aReagents: (a) 10-(Tetrahydro-2H-pyran-2-yloxy)decanal, piperidine, CH3CN; (b) TBDMSCl, imidazole, DMF; (c) MgBr2-Et2O, ether; (d)
bleach,Tempo,NaBr,Bu4NBr,NaHCO3,CH 2Cl2/H2O;(e)DIBAL-H,Et3N,CH2Cl2;(f)Dess-Martinperiodinane,CH2Cl2;(g)HFaq,CH 3CN;
(h) Diazald, KOH, H2O/EtOH, ether.362 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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several deprotection conditions, HF deprotection resulted in
minimaldecomposition ofthealdehyde moiety.Intermediate12
was converted to its corresponding methyl ester using diazo-
methane. Attempts to esterify using acidic methanol resulted in
low yields due to allylic substitution. The same oxidation and
deprotection conditions described above were employed to
generate the final compounds COOMe-HNE and -ONE.
Lipid Electrophile Toxicity: Cell Viability Assay. The cyto-
toxicityofeachlipidelectrophilewasdeterminedbyperforminga
cell viability assay and generating a concentration-response
curve. Cell viability was measured following a 24-48 h incuba-
tionwiththecompound,usingthefluorogenicsubstrate,calcein-
AM. In live cells, calcein-AM is cleaved by an endogenous
esterase to produce the fluorescent molecule, calcein. Therefore,
cell viability can be directly correlated with fluorescent intensity.
IC50 values were calculated from a plot of log of concentration
versusthepercentoffluorescenceascomparedtovehicle-treated
cells(Figure1).Eachlipidelectrophilewasassayedfortoxicityin
two cell types, human colorectal carcinoma, RKO, cells and
human acute monocytic leukemia, THP-1, cells. The RKO cells
were used in order to compare compound toxicity with previous
electrophile studies from our laboratory, and the THP-1 cells
were used to focus on the ability of lipid electrophiles to
modulate the inflammatory process.
The IC50 values reported in Table 1 indicate that HNE, ONE,
ONEA, and COOMe-HNE/ONE all have similar potency with
regards to cellular toxicity (IC50 =2 0 -47 μM) in RKO cells.
Previousstudiesfromourlaboratorydemonstratedtheactivation
of caspase-3 and PARP cleavage, indicative of the induction of
apoptosis, at similar concentrations of HNE and ONE.
33 ONEA
demonstratesgreaterthan10-foldhighertoxicitythanitscounterpart
HNEA. Additionally, COOH-ONE shows much greater toxicity
than its hydroxy HNE analogue COOH-HNE. Conversion of
COOH-HNE/ONE to a carboxy-methyl ester led to a decrease in
IC50 values for the COOMe derivatives with a more pronounced
eﬀect in the HNE derivatives as compared to the ONE derivatives.
Increased toxicityoftheCOOMederivatives is mostlikelydue to an
increased uptake of the neutral molecules, as the charged carboxylic
acid moiety can inhibit diﬀusion across the cell membrane.
The overall trend for the viability assays is that the ONE
analogues are more toxic than the HNE analogues. These data
corroborate previous literature reports, which argue that ONE is
more reactive than HNE. However, in our hands the parent
compoundsthemselves,ONEversusHNE,showlittlediﬀerence
in toxicity. Prior reports indicate that HNE and ONE are
equitoxic in RKO cells or that ONE is 5-fold more toxic than
HNE in human neuroblastoma cells.
33,34 To address this issue,
we repeated the viability assay for HNE and ONE in the absence
of serum to determine if ONE’s apparent toxicity was lowered
because of its higher reactivity with serum proteins, as compared
to HNE. In RKO cells treated in theabsenceof serum,HNEand
ONE both exhibited greater toxicity with IC50 values of 5 and
9 μM, respectively (data not shown). However, HNE and ONE
exhibit similar toxicity in the absence of serum suggesting that
serumreactivitydoesnotexplainwhytwoelectrophileswithvery
divergent chemical reactivity have nearly identical toxicities.
TheIC50values inTHP-1 cellsshow remarkableconcordance
withthosevaluesobtainedfortheRKOcells.Thetoxicitydatain
THP-1 recapitulates the overall trend observed in the RKO cells
with the ONE analogues being more toxic than their respective
HNE analogues.
Relative Reactivity of Electrophiles. In order to determine
the relative reactivity of the lipid electrophiles, the reaction of
Figure1. THP-1cellviabilityassayforselectlipidelectrophiles.THP-1
cells were treated with various concentrations of lipid electrophiles for
24 h, and cell viability was assayed using the ﬂuorescent substrate
calcein-AM. IC50 values were determined from a plot of log of electro-
phile concentration versus percent of live cells as compared to a vehicle
(DMSO) control.
Table 1. IC50 Values for Lipid Electrophiles in RKO and
THP-1 Cells
aRKO cells were seeded into 96-well plates (7.5   10
3 cells/well).
After 24 h, cells were challenged with various concentrations of the
lipidelectrophile(0-500μM)inthepresenceofserum.Followinga
24-48 h treatment, the cells were washed with PBS and incubated
with 2μMcalcein-AM. Fluorescence wasmonitored at 517 nm,and
cell viability was correlated with fluorescent intensity. THP-1 cells
were seeded into 96-well plates (3   10
4 cells/well) and treated with
100 nM PMA for 72-96 h to differentiate. Following differentia-
tion, cells were challenged with the lipid electrophile for 24 h before
being read using the calcein AM assay (described above).363 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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each compound with N-acetyl cysteine (NAC) was investigated.
Since the reactive moiety of most of the compounds was
essentially unchanged from the parent HNE and ONE, we
anticipated that these compounds would also undergo a Michael
addition with NAC. Upon reaction, the characteristic chromo-
phoreduetotheR,β-unsaturatedcarbonylwouldbelost,andthe
consumption could therefore be followed by UV.
The reaction ofeachelectrophile withNAC was carried outin
phosphate buﬀer (pH 7.4) at 37 C under pseudoﬁrst-order
conditions. In addition, the stability of each electrophile to the
reactionconditionswas investigatedintheabsenceofNAC.The
reaction of the electrophile was monitored by UV at 225 or 230
nmforHNEorONE,respectively.UponreactionwithNAC,the
absorbance at these wavelengths decreased until the electrophile
had been completely consumed. The reaction was continued
until at least 5 half-lives had been reached (see Supporting
Information). In most cases, some background absorbance
remained; therefore, the data were corrected for this residual
absorbance.
The UV absorbance for most of the analogues was similar to
those of their parent compound. However, the λmax for HNEA
wasshiftedfrom225to210nm.SinceitispossiblethattheNAC
or Michael adducts could also absorb in that region, the reaction
of HNEA with NAC was also analyzed by HPLC. The sample
was made up in phosphate buﬀer as described above, with the
addition of an internal standard. The amount of HNEA relative
to the standard was measured over time.
The stability and reactivity of each electrophile is presented in
Figure 2. All of the compounds were stable to the reaction
conditions, represented by the open symbols in the ﬁgure. Upon
addition of NAC, all of the electrophiles except HNEA reacted,
resulting in a decrease in the UV absorbance (closed symbols).
COOMe-HNE and COOMe-ONE (squares) exhibited reactiv-
itiessimilartothoseoftheirparentcompounds(triangles),while
COOH-HNE and COOH-ONE (circles) were slightly less
reactive. Substitution of the aldehyde moiety with a carboxylic
acid had a signiﬁcant impact on the reactivity of the HNEA and
ONEA with NAC. HNEA, as analyzed by UV and HPLC,
showed no reaction. Although the ONEA reacted with NAC,
its reactivity was much slower than that of ONE and was
comparable to that of the HNE analogues.
First-order plots (see Supporting Information) of the data in
Figure2wereusedtocalculatethehalf-livesfortheseriesofHNE
and ONE analogues at 1 mM NAC. The second-order rate
constant for each electrophile was determined from plots of the
k1atvaryingconcentrationsof NAC(datapresentedinSupport-
ing Information). The half-lives and second-order rate constants
for each electrophile are presented in Table 2.
EffectofContinuousHNEExposureonCytokineExpression.
Previous literature reports have shown that low concentra-
tions of HNE (1-10 μM) can inhibit the production of
various pro-inflammatory cytokines, IL-6, TNFR, and IL-1β,i n
several macrophage cell lines.
22,35 To recapitulate these experi-
ments in our model system, THP-1 macrophages were pre-
treated with various concentrations of HNE for 30 min before
the addition of LPS/IFNγ and 6 h of activation. Medium was
collected from the treated cells and assayed by ELISA for the
expression of the pro-inflammatory cytokines IL-1β and IL-6.
Figure2. Stability(opensymbols)andreactivity(closedsymbols)ofHNEandONEanalogues.(A)HNEwith(ﬁlledredtriangle)andwithout(open
red triangle) NAC, COOH-HNE with (ﬁlled blue circle) and without (open blue circle) NAC, COOMe-HNE with (ﬁlled black square) and without
(open blacksquare) NAC; (B)ONEwith (ﬁlledred triangle) and without (open redtriangle) NAC, COOH-ONEwith (ﬁlledbluecircle) andwithout
(open blue circle) NAC, COOMe-ONE with (ﬁlled black square) and without (open black square) NAC; (C) HNEA with (ﬁlled blue circle) and
without(openredtriangle)NAC;(D)ONEAwith(ﬁlledbluecircle)andwithout(openredtriangle)NAC.Reactionswerecarriedoutwith0.056mM
electrophile and 1 mM NAC in phosphate buﬀer (50 mM, pH 7.4) at 37 C. The consumption of the electrophile was monitored by UV absorbance at
225 and 230 nm for HNE and ONE, respectively.364 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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Under continuous HNE exposure, IL-1β exhibited a biphasic
decline of expression whereby at low concentrations of HNE
(0.01-0.5 μM), there was a gradual loss of cytokine expres-
sion to about 80% of DMSO control. At higher concentrations,
t h e r ew a sad r a m a t i cl o s si nI L - 1 β expression with complete
inhibition at concentrations greater than 25 μM( F i g u r e3 A ) .
Measurement of IL-6 expression showed similar results with
minimal loss of IL-6 expression at low concentrations of HNE
(0.1-1 μM)followedbyasharpdeclineincytokineexpression
above 5 μM HNE (Figure 3B). The sharp decline in cytokine
expression at doses exceeding 5 μM HNE cannot be explained
by a loss in cell viability. Previous studies from our laboratory
evaluating HNE induction of apoptosis as measured by PARP
cleavage and caspase-3 activation showed no evidence of
apoptosis up to 8 h after treatment with 45 μMH N E .
33
InhibitionofPro-InflammatoryCytokinesafterAcuteHNE
or ONE Exposure. Although no evidence of cell death was
found which could account for the loss of cytokine expression
during continuous HNE exposure, we chose to modify our
protocol to eliminate any potential for toxicity during the course
of the experiment. To this end, all cytokine experiments were
conducted by treating THP-1 cells for short periods of time with
various concentrations of lipid electrophile, washing with PBS to
remove any electrophile, and then challenging the cells with
LPS/IFNγ.Wemonitored thecytokinesIL-6,IL-1β,andTNFR
because of their key role in the progression/activation of the
macrophage inflammatory response and because of previous
literature reports which indicate a role for HNE and oxPLs in
their inhibition.
21-23 ELISAs specific for each of the pro-
inflammatory cytokines were used to analyze the conditioned
medium from THP-1 macrophages treated with various concen-
trationsofHNE,ONE,andvehiclecontrol.Briefly,theassaywas
a solid phase sandwich ELISA in which a monoclonal antibody,
specific to the cytokine of interest, was coated on a 96-well plate.
Any target protein in the conditioned medium was immobilized
by binding to the antibody on the plate. The plate was then
washed and developed by adding a second biotinylated antibody
and a streptavidin-horseradish peroxidase conjugate. The ELI-
SA is sensitive for an individual cytokine and utilizes a standard
curve for quantification of the specific cytokine. Preliminary
studies using both ELISAs and Western blotting were used to
assay THP-1 macrophages exposed to subcytotoxic doses of
HNE and ONE for varying periods of time (5 min-1 h) before
washout and LPS/IFNγ challenge. From this work, it was
determined that subcytotoxic doses of electrophiles could effi-
ciently inhibit cytokine production in as little as 30 min of
pretreatment (data not shown). Therefore, 30 min of pretreat-
ment with electrophile was used for our cytokine inhibition
experiments.
After 30 min of pretreatment with 5 or 10 μM HNE or ONE
followed by washout, there was a 20-60% decrease in the levels
of IL-6 in the medium following 6 h of LPS challenge
(Figure 4A). It is interesting to note that ONE aﬀorded less
cytokine inhibition than HNE at both the 5 and 10 μM
concentrations, even though both compounds exhibit similar
toxicity proﬁles. Under similar conditions, HNE inhibited LPS-
induced TNFR by 30% at 5 μM and 40% at 10 μM (Figure 4C).
HNE was also assayed for its ability to inhibit IL-1β over a 24 h
time course. HNE repressed LPS induction of IL-1β expression
by up to 80% 24 h after HNE pretreatment and washing
(Figure 4B). These data suggest that HNE works rapidly to
modify a putative target(s), which mediates the inhibition of IL-
1βexpression.Thisinhibitoryeﬀectpersistsfor24hafterHNEis
removed from the cells. These data indicate that HNE has the
strongestinhibitoryeﬀectonIL-1βproduction,followedbyIL-6,
and to a lesser extent TNFR.
A dose-response curve was generated for IL-1β and IL-6
expression using the 30 min electrophile treatment protocol to
compare with the dose-response curve resulting from contin-
uousHNEexposure(Figure3AandB).UnlikecontinuousHNE
exposure, theIL-1βlevels inthe acute HNEtreatment condition
showed no decrease at low concentrations (0.01-0.5 μM) of
HNE. However, at higher concentrations of HNE there was
comparable loss of cytokine expression between the continuous
and transient treatment conditions. Transient HNE exposure
Table2. Half-LivesandSecondOrderRateConstants forthe
Reaction of HNE, ONE, and their Analogues with N-Acetyl
Cysteine
electrophile half-life (s)
a k (M
-1 s
-1)
b
HNE 732 ((44) 1.22 ((0.08)
HNEA NR NR
COOH-HNE 1213 ((116) 0.79 ((0.11)
COOMe-HNE 794 ((48) 1.18 ((0.08)
ONE 7.1 ((0.6) 238 ((13)
ONEA 580 ((40) 1.72 ((0.28)
COOH-ONE 13.9 ((0.7) 169 ((7)
COOMe-ONE 7.1 ((0.5) 301 ((9)
aHalf-life determined in the presence of 1 mM NAC in phosphate
buffer (50 mM, pH 7.4) at 37 C.
bRate constant determined in
the presence of varying concentrations of NAC in phosphate buffer
(100 mM, pH 7.4) at 37 C.
Figure 3. Eﬀect of continuous vs transient HNE treatment on cytokine
expression during LPS/IFNγ challenge. THP-1 cells were pretreated
with various concentrations of HNE for 30 min, followed by either
leaving in or washing out (w.o.) the electrophile, and 6 h of LPS
challenge. HNE was assayed for its ability to inhibit IL-1β (A) and IL-6
(B) expression.365 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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produced a similar curve for the inhibition of IL-6 synthesis as
comparedtocontinuousexposurewherebylowerconcentrations
ofHNE(0.01-5μM)aﬀordedminimalinhibitionofexpression,
and higher concentrations (10 μM or higher) produced a steep
decline in levels of IL-6.
Viability assays were performed using comparable conditions
to 30 min of electrophile treatment to determine if cell death
causedthecytokineinhibition.THP-1macrophagesweretreated
for 30 min with HNE, washed, and their viability assayed after a
24hincubation.Notoxicitywasobservedat5-10μMHNEand
less than 25% cell death was observed at concentrations of HNE
>100 μM. Therefore, cell death during the 6 h of LPS activation
cannot account for the dramatic decrease in cytokine expression
that is observed with higher concentrations of HNE (data not
shown).
Inhibition of IL-6 Expression by HNE. ELISA assays mea-
sure only secreted proteins; therefore, it was necessary to
recapitulate these results by using Western blot to assay cyto-
kines from cell lysates. THP-1 cells were treated with HNE at
concentrations of 0-10 μM for 5-30 min time periods before
being removed by washing twice with PBS. Cells were then
challenged with LPS/IFNγ for 6 h to induce an inflammatory
response. Western blots were used to probe cell lysates for lipid
electrophile-mediatedchangesinthepro-inflammatorycytokine,
IL-6. Partial inhibition of IL-6 induction by LPS was observed at
the 5 μM dose of HNE, and complete inhibition was observed at
the10μMdosefor30min(Figure5).Theseresultsconfirmthat
the changes in IL-6 cytokine levels, seen in the ELISA assays, are
due to the inhibition of cytokine expression rather than the
electrophile-mediated inhibition of cytokine secretion.
HNE Inhibition of IL-6 Is Dependent on the Duration of
Incubation Between Electrophile Washout and LPS challenge.
To examine whether the effect of HNE on cytokine inhibition was
transient, THP-1 macrophages were treated with 10 μMH N Eo r
vehicle control for 30 min, and then, the electrophile was washed
out. The cells were either immediately challenged with LPS/IFNγ
or incubated for 30 min or 3 h before challenge. After 6 h of LPS
treatment, the cell lysatewas examined by Western blotfor levelsof
IL-6. When cells were pretreated with HNE, washed, and immedi-
atelychallengedwithLPSfor6h,therewasacompleterepressionof
IL-6 expression. However, if LPS challenge was delayed for 30 min
there was a 50% reduction in IL-6 repression, and after delaying
LPS challenge for 3 h, there was no observable repression of IL-6
synthesis (Figure 6).
Dependence of Cytokine Inhibition on Lipid Electrophile
Reactivity. To test whether there was a correlation between
electrophile reactivity and cytokine inhibition, several pairs of
HNE/ONE analogues were assayed for their ability to inhibit
cytokine synthesis over a broad concentration range. The most
divergent pair of analogues in terms of reactivity, HNEA and
ONEA, were assayed for their ability to inhibit IL-1β, IL-6, and
TNFR. THP-1 macrophages were treated with HNEA/ONEA
for 30 min, the compounds were removed by washing, and then
the cells were challenged for 6 h with LPS/IFNγ. At low
concentrations, 0-1 μM HNEA or ONEA, there was a decrease
in IL-1β levels to approximately 40% of the vehicle control
(Figure 7A). However, at concentrations of 5 μM and above the
compounds diverge in terms of their ability to inhibit IL-1β
production. Increasing concentrations of ONEA led to a com-
plete loss of IL-1β expression at a concentration of 50 μM,
whereas increasing concentrations of HNEA showed no effect as
Figure 4. Inhibition of cytokine expression by HNE and ONE. IL-6
ELISA of conditioned media from THP-1 macrophages pretreated with
HNEorONE(30min),washed,andchallengedwithLPS/IFNγfor6h
(A). IL-1β (B) or TNFR (C) ELISA of media from THP-1 cells
pretreated with HNE for 30 min, washed, and challenged with LPS
for the times indicated (6 h LPS challenge for TNFR ELISA).
Figure 5. IL-6 Western blot of cell lysate from THP-1 macrophages
pretreated with HNE, washed, and challenged with LPS for 6 h. The
lysate was probed with either anti-IL-6 or antiactin antibodies.
Figure 6. Recovery of IL-6 synthesis by delaying the time between LPS
challenge and HNE treatment. Western blot for IL-6 from THP-1
macrophage cell lysate. Cells were pretreated with 10 μM HNE or the
vehicle control for 30 min followed by washing with PBS. Following
washout ofthe electrophile, cells were challenged with LPS/IFN-γ after
anincubationtimeof0,0.5,or3h.Thecelllysatewasprobedwitheither
anti-IL-6 or anti-actin antibodies.366 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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IL-1β returned to control levels. Levels of IL-6 remained
relatively unaffected by both HNEA and ONEA at concentra-
tions of 0-1 μM (Figure 7B). At concentrations of ONEA
greater than 5 μM, there was a decline in IL-6 expression with a
complete loss of expression at 200 μM. No change in IL-6
expression was apparent with concentrations of HNEA up to
200 μM. At low concentrations of HNEA (0-1 μM), TNFR
expression was inhibited in a manner similar to that in IL-1β,
with loss of expression to approximately 50% of the control
(Figure 7C). However, at higher concentrations of HNEA (>5
μM) there was no apparent inhibition of TNFR expression.
ONEA afforded no inhibition of TNFR at concentrations up to
50 μM but produced a steep decline in expression at concentra-
tions above 50 μM.For thesetwocompounds, thereseems tobe
a correlation between electrophile reactivity and cytokine inhibi-
tion. At concentrations of 5 μM and greater, the reactive ONEA
had a greater inhibitory effect on pro-inflammatory cytokines as
compared to HNEA, which exhibited little cytokine inhibition
and no reactivity.
COOMe-ONE is approximately 100-fold more reactive than
its analogue COOMe-HNE. However, both compounds display
reactivity and toxicity nearly identical to those of their respective
parent compounds. Therefore, these compounds were assayed
for their ability to inhibit cytokine synthesis to determine if their
inhibitory properties mimicked their respective parent com-
pounds and to determine if there was a similar correlation
between reactivity and cytokine inhibition as seen with the
HNEA and ONEA compounds. With the exception of TNFR,
the COOMe-HNE and COOMe-ONE compounds gave similar
cytokine inhibition proﬁles. There was minimal loss of cytokine
expression(lessthan20%)atconcentrationsof0-10μM,andat
higher concentrations, there was a steep decline in cytokine
expression whereby cytokine expression was nearly zero at
concentrations of electrophile greater than 25 μM (Figure 8A
and B). In the case of TNFR, COOMe-HNE was more active
than COOMe-ONE and aﬀorded greater than 40% inhibition at
concentrations of 0.5 μM and higher, while COOMe-ONE
required10-foldhigherconcentrationstoproduceasimilareﬀect
(Figure8C). Strictly onthe basis ofreactivityproﬁles,there does
not appear to be any correlation between reactivity and cytokine
Figure 7. Inhibition of cytokine expression following acute exposure to
HNEA and ONEA. IL-1β ELISA (A), IL-6 ELISA (B), and TNFR
ELISA (C) of conditioned media from THP-1 macrophages pretreated
with HNEA or ONEA (30 min), washed, and challenged with LPS/
IFNγ for 6 h.
Figure 8. Inhibition of cytokine expression following treatment with
COOMe-HNE and COOMe-ONE. IL-1β ELISA (A), IL-6 ELISA (B),
and TNFRELISA (C) of conditioned media from THP-1 macrophages
pretreated with COOMe-HNE or COOMe-ONE (30 min), washed,
and challenged with LPS/IFNγ for 6 h.367 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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inhibition as the COOMe-ONE is 100-fold more reactive than
COOMe-HNE, but both compounds exhibit similar cytokine
inhibitoryproperties.Additionally,boththeCOOMederivatives
are less eﬀective at inhibiting cytokines as compared to their
respective parent compounds under comparable conditions. At
10 μM HNE, cytokine inhibition for all three cytokines is 40-
60%, whereas at 10 μM COOMe-HNE, there is only 10-20%
cytokine inhibition. Taken as a whole, these data suggest that
there is no simple correlation between electrophile reactivity,
toxicity, or anti-inﬂammatory activity.
Inhibition of THP-1 Macrophage Phagocytosis by HNE
and ONE. Cytokine expression is only one method of assessing
macrophage activation and the inflammatory response; there-
fore, we also analyzed changes in the ability of THP-1 macro-
phages to phagocytose fluorescent beads following pretreatment
with HNE or ONE. Phagocytosis is critical to the activation of
theimmuneresponsebecauseitleads toantigen presentation on
the cell surface of the ingesting macrophage and subsequent
activation of other macrophages and immune cells. Macrophage
activation was assayed by using fluorescence microscopy to
visualize the phagocytosis of fluorescent beads by differentiated
THP-1 macrophages following 30 min of lipid electrophile
treatment and removal (Figure 9 A). HNE and ONE inhibited
phagocytosis by 20-40% after 3 h; however by 6 h, inhibition of
phagocytosis was observed only in those cells pretreated
with HNE (Figure 9 B). Importantly, the conditions of electro-
phile dosage and treatment duration used in these experiments
are identical to those conditions found to inhibit cytokine
production.
’DISCUSSION
Lipid electrophiles, produced enzymatically or under condi-
tions of oxidative stress, are signiﬁcant mediators of intracellular
signaling. The best characterized of these electrophile mediators
is HNE, which activates and inhibits complex networks of cell
signaling and gene expression, induces the intrinsic and extrinsic
pathwaysofapoptosis,andmodulatestheinﬂammatoryresponse
atthecellularlevel.HNEhasbeenshowntoinhibitproductionof
the pro-inﬂammatory cytokines, TNFR, IL-1β, and IL-6 in
several monocytic/macrophage cell lines.
21-23 Here, we deﬁned
the toxicity proﬁle, the relative reactivity, and the anti-inﬂam-
matory properties of a number of previously uncharacterized
HNE analogues resulting from phospholipid oxidation. Addi-
tionally, we characterized the anti-inﬂammatory properties of
another reactive electrophile, ONE, and its analogues.
ViabilitydataforHNE,ONE,andtheiranaloguesindicatethat
with the exception of the parent compounds, the ONE series of
derivatives are more toxic than their respective HNE analogues.
HNEA exhibited no toxicity under any conditions, which is
consistentwithpreviousstudiesinneuroblastomacellswherethe
compound did not produce cell death when used in concentra-
tions exceeding 300 μM.
18 In contrast, ONEA had toxicity
comparable to that of the parent compound ONE. This loss of
toxicity results from the replacement of the aldehyde with the
more electron-rich carboxylate anion, which deactivates the
C2dC3 double bond of HNEA toward Michael additions with
thiol or amino groups.
36 ONEA is less aﬀected by this substitu-
tionbecauseitretains anR,β-unsaturatedketone whichservesas
a Michael acceptor.
19 COOH-HNE and COOH-ONE exhibit a
similar divergence in toxicity as compared to the HNEA/ONEA
analogues.Bothcompoundsexhibitlowertoxicityoverallrelative
to the parent compounds, primarily due to the charge on the
carboxylic acid moiety, which inhibits entry of the compounds
into the cell. While it is unclear whether charge state completely
explainsthedivergenceintoxicityorifthediﬀerenceintoxicityis
due to COOH-ONE mediating its toxicity via a unique mecha-
nism at the cell surface, there is strong evidence that charge state
plays a critical role in compound toxicity as the methyl ester
Figure 9. Inhibition of phagocytosis by THP-1 macrophages following pretreatment with lipid electrophiles. Fluorescent microscopy images (GFP
Filter) of THP-1 macrophage phagocytosis following 30 min of pretreatment with the DMSO vehicle, 10 μM HNE, or 0.5 μM ONE and washout with
PBS. Phagocytosis of ﬂuorescent polystyrene latex beads after 3 h (A). Quantiﬁcation of ﬂuorescent bead uptake by THP-1 macrophages following
pretreatmentwithelectrophiles,washout,andexposuretoﬂuorescentbeadsfor3or6h(B).*p-value<0.05;**p-value<0.01ascomparedtothe3hand
6 h vehicle (DMSO) control, respectively.368 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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derivativesof ONEandHNEhave toxicity similartothatof each
other and the parent compounds.
The reactivity proﬁles for each electrophile with N-acetyl
cysteine followed trends similar to those of the toxicity data
and are consistent with those values reported in the litera-
ture.
37,38 In general, the ONE compounds were both more
reactive and toxic than their HNE analogues. Additionally, the
COOMe-HNE/ONE derivatives demonstrated comparable re-
activity tothose of theparentcompounds, whichis in agreement
with the similarity in toxicity data between these analogues.
HNEA exhibited no measurable activity with NAC, which is also
consistent withits lackoftoxicityandprevious datashowing that
HNEA does not form protein adducts.
18 The one main incon-
sistency between the toxicity data and the relative reactivity data
is for the parent compounds, HNE and ONE. ONE is greater
than100-foldmorereactivethanHNE,andyetbothcompounds
are identical in terms of IC50 values. Previous work in neuro-
blastoma cells has shown ONE to be as much as 31 times more
reactive with proteins than HNE and has also demonstrated
4-5 times greater toxicity with ONE as compared to HNE.
34
The higher reactivity but similar toxicity of ONE to HNE in our
system could be caused by a number of factors. It has been
suggested that ONE is highly reactive such that its eﬀective
concentration could be reduced (i.e., by reacting with FBS in the
media)beforeeverenteringthecell.Viabilityassaysconductedin
our laboratory using RKO cells treated with HNE and ONE in
thepresenceorabsenceofserumdemonstratethatthisisnotthe
case, as both HNE and ONE treated cells exhibit a similar 5-fold
decrease in their IC 50 values in the absence of serum, suggesting
thatserumreactivitydoesnotaccountfordiﬀerencesinreactivity
but similarities of toxicity. Other possible explanations for these
results are (1) ONE is removed more eﬀectively by detoxifying
mechanisms within the cell, such as spontaneous or catalyzed
reactions with glutathione or via electrophile metabolizing en-
zymes. There is precedent in the literature for detoxifying
enzymes such as aldehyde dehydrogenase that demonstrate
selectivity in their ability to neutralize reactive electrophiles.
39
(2) In any lipid electrophile-mediated signaling event, the
biological activity represents the rate-limiting step. For many
signaling events, only a subpopulation of proteins must be
modiﬁed in order to mediate downstream eﬀects. The reaction
ofHNEandONEwithagivenprotein,whilea100-folddiﬀerent
in rate, is likely to occur more rapidly than the expression of
transcription factors and changes in downstream gene expres-
sion. Thus, the rate-limiting step in the cellular response is likely
to be biological rather than chemical. (3) ONE and HNE have
greater than 100-fold diﬀerence in reactivity toward cysteine
residues. However, this diﬀerence in the ratio of reactivity is less
dramatic when considering reactivity with histidine and lysine
residues. Additionally, there is no correlation between rapid
electrophile-protein residue reactivity and toxicity.
40 The toxi-
city is dependent more on what role the modiﬁed residue has in
the proper folding and functioning of the protein.
40
Alloftheelectrophilesassayed(withtheexception ofHNEA)
were able to inhibit the production of the pro-inﬂammatory
cytokines IL-1β, IL-6, and TNFR to varying degrees. These data
are consistent with literature reports that describe inhibition of
the production of the same cytokines in LPS-activated mono-
cytes treated with HNE or oxPLs. There was also a general trend
toward greater cytokine inhibition in cells treated with the more
toxic/reactive electrophiles (i.e., HNE, ONEA, and COOMe-
ONE). With regards to individual cytokines, IL-1β expression
was most aﬀected by treatment with lipid electrophiles, whereas
TNFR expression was least aﬀected by electrophile treatment.
Inhibition of IL-1β expression could be observed with lower
concentrations of the electrophile, as in the cases of ONEA,
HNE, and COOMe-ONE where 20-60% inhibition was ob-
served following treatment with 1 μM or less of the compound.
Taken as a whole, these data that characterize diﬀusible lipid
electrophilesprovideaninterestingcontrasttomembranebound
oxidized phospholipids, which can promote pro-inﬂammatory
signaling. Oxidized PLs with HNE/ONE-like carbonyl groups at
the sn-2 position can be generated in the plasma membrane and
promote macrophage activation and inﬂammation. These oxPLs
undergo a conformational change that shifts hydrophobic por-
tionsoftheirfattyacylchainsfromtheinteriorlipidbilayertothe
external aqueous environment. This phenomenon is referred to
as “growing (lipid) whiskers”.
20,41,42 OxPL whiskers may permit
an interaction with macrophage CD36 scavenger receptors
leading to their activation and a pro-inﬂammatory response. At
this time, it is unclear whether the pro- vs anti-inﬂammatory
behavioroflipidperoxidationproductsisrelatedtotheirlocation
in the membrane or ability to diﬀuse throughout the cell.
Dose-response curves were generated to assay cytokine
expression in response to acute or chronic HNE exposure.
Consistent with our other ﬁndings, IL-1β expression shows the
most sensitivity to electrophile treatment conditions (acute vs
chronic). Under conditions of continuous treatment with the
electrophile, there appear to be two phases in the concentration
dependence for inhibition of cytokine production, one at lower
concentrations (0.01-1 μM) and another at higher concentra-
tions (greater than 5 μM) that is not seen with transient
treatment conditions or with IL-6 under transient or continuous
conditions. These data suggest the possibility of HNE reversibly
binding to a high-aﬃnity target associated with IL-1β inhibition.
Such binding/inhibition could be readily reversible and thereby
be lost upon removal of electrophile during washing. At higher
concentrations of HNE, a second lower aﬃnity and more slowly
reversible target may be accessed which could play a greater role
ininhibitingIL-1βexpression.ThefactthatHNEAinhibitscyto-
kine expression at low concentrations, especially for TNFR
expression,suggeststhatcovalentmodiﬁcationofaproteintarget
may not be essential to inhibit expression.
For transient HNE exposure, IL-6 cytokine expression is
impacted by the duration of incubation between electrophile
washout and LPS challenge. Loss of IL-6 repression by delaying
LPS challenge suggests that the HNE-protein adduct(s) respon-
sible for the inhibition of IL-6 have a short half-life. Whether this
short half-life is due to active removal/degradation of the HNE-
protein adduct by cellular machinery or rapid reversibility of the
HNE-protein adduct is unclear.
There are several unanswered questions that need to be
explored relating to the mechanism(s) by which lipid electro-
philes mediate the inhibition of pro-inﬂammatory cytokines and
whether individual electrophiles mediate their eﬀects by activat-
ing the same cellular signaling pathways. To address these issues,
we and ourcollaboratorsare using aclickchemistrybased approach
whereby THP-1 cells are treated with alkynylated electrophiles
and reacted with an azido compound containing an aﬃnity tag to
enrich for protein targets of individual electrophiles. This method
willallowustogenerateaninventoryofproteinsthataremodiﬁed
by individual electrophiles. Inventories from electrophiles
with diﬀerent biological properties may provide insights into
themoleculartargetsresponsiblefortheirbiologicalactivities.369 dx.doi.org/10.1021/tx100323m |Chem. Res. Toxicol. 2011, 24, 357–370
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